{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:45:39Z","timestamp":1791805539599,"version":"4.3.4"},"reference-count":30,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Brazilian National Research Council","award":["420318\/2023-2"],"award-info":[{"award-number":["420318\/2023-2"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cad. Sa\u00fade P\u00fablica"],"DOI":"10.1590\/0102-311xen052426","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T10:56:59Z","timestamp":1791802619000},"source":"Crossref","is-referenced-by-count":0,"title":["Trump and mRNA technologies: global health risks and opportunities in vaccine manufacturing diversification"],"prefix":"10.1590","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1385-7957","authenticated-orcid":false,"given":"Henrique Zeferino de","family":"Menezes","sequence":"first","affiliation":[{"name":"Universidade Federal da Para\u00edba","place":["Jo\u00e3o Pessoa, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4010-4835","authenticated-orcid":false,"given":"Kenneth C.","family":"Shadlen","sequence":"additional","affiliation":[{"name":"London School of Economics and Political Science","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref1","series-title":"United States completes WHO withdrawal."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJMp2501790","article-title":"Withdrawal of the United States from the WHO - how President Trump is weakening public health","volume":"392","author":"Yamey G","year":"2025","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"100787","DOI":"10.1016\/j.jvacx.2026.100787","article-title":"The journey towards mRNA vaccine technology transfer from knowledge to implementation","volume":"29","author":"Fenner C","year":"2026","journal-title":"Vaccine X"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2471\/BLT.24.291388","article-title":"An mRNA technology transfer programme and economic sustainability in health care","volume":"102","author":"Dutt D","year":"2024","journal-title":"Bull World Health Organ"},{"key":"ref5","series-title":"mRNA Technology Transfer Programme's Phase 2.0 discussed with partners on the sidelines of G20 Summit 2025."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/S0140-6736(25)01016-5","article-title":"The potential impact of the Trump administration policies on health research in the USA","volume":"405","author":"Woolf SH","year":"2025","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1590\/0102-311xen027025","article-title":"Trump 2 at war with science.","volume":"41","author":"Camargo Jr. KR","year":"2025","journal-title":"Cad Sa\u00fade P\u00fablica"},{"key":"ref8","series-title":"HHS winds down mRNA vaccine development under BARDA."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"s287","DOI":"10.1136\/bmj.s287","article-title":"US and Moderna FDA refuses approval process for new mRNA flu vaccine","volume":"392","author":"Baraniuk C","year":"2026","journal-title":"BMJ"},{"key":"ref10","article-title":"How RFK Jr.'s misguided science on mRNA vaccines is shaping policy - a vaccine expert examines the false claims.","author":"Fuller D","year":"2025","journal-title":"The Conversation"},{"key":"ref11","article-title":"FDA reverses course, agrees to review Moderna's flu vaccine.","author":"Lawrence L","year":"2026","journal-title":"STAT"},{"key":"ref12","first-page":"101173","article-title":"Trump's second presidency begins evaluating effects on the US health system","volume":"48","author":"Greer SL","year":"2025","journal-title":"Lancet Reg Health Am"},{"key":"ref13","series-title":"AMM statement in response to recent actions by the US Department of Health and Human Services regarding mRNA technology."},{"key":"ref14","article-title":"Moderna is curbing investment in vaccine trials due to US backlash.","author":"Smith G","year":"2026","journal-title":"Bloomberg"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(21)00306-8","article-title":"Challenges in ensuring global access to COVID-19 vaccines production, affordability, allocation, and deployment","volume":"397","author":"Wouters OJ","year":"2021","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/vaccines13010056","article-title":"Exploring future pandemic preparedness through the development of preventive vaccine platforms and the key roles of international organizations in a global health crisis","volume":"13","author":"Jeon J","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"101226","DOI":"10.1016\/j.lanmic.2025.101226","article-title":"Protecting the future of vaccine development amidst US funding withdrawal for mRNA vaccine research","volume":"6","author":"Petersen E","year":"2025","journal-title":"Lancet Microbe"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","article-title":"mRNA vaccines for infectious diseases - advances, challenges and opportunities.","volume":"23","author":"Pardi N","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/S0140-6736(22)00793-0","article-title":"Closing the global vaccine equity gap equitably distributed manufacturing","volume":"399","author":"Dzau VJ","year":"2022","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-007031","article-title":"New waves, new variants, old inequity a continuing COVID-19 crisis","volume":"6","author":"Saha S","year":"2021","journal-title":"BMJ Glob Health"},{"key":"ref21","series-title":"WHO Pandemic Agreement."},{"key":"ref22","first-page":"9192","article-title":"From aspiration to action aligning the pandemic agreement with equity in vaccine access; a response to recent commentaries","volume":"14","author":"Borges LC","year":"2025","journal-title":"Int J Health Policy Manag"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1016\/j.vaccine.2020.05.062","article-title":"Two decades of vaccine innovations for global public good report of the Developing Countries' Vaccine Manufacturers Network 20th Meeting, 21-23 october 2019, Rio de Janeiro, Brazil","volume":"38","author":"Pagliusi S","year":"2020","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.vaccine.2021.02.017","article-title":"Building the global vaccine manufacturing capacity needed to respond to pandemics","volume":"39","author":"Sell TK","year":"2021","journal-title":"Vaccine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.vaccine.2020.12.085","article-title":"Advancing innovation for vaccine manufacturers from developing countries prioritization, barriers, opportunities","volume":"39","author":"Hayman B","year":"2021","journal-title":"Vaccine"},{"key":"ref26","series-title":"The mRNA vaccine technology transfer programme."},{"key":"ref27","series-title":"Latin America and the Caribbean advance mRNA vaccine development against influenza A(H5N1) with PAHO support."},{"key":"ref28","series-title":"Fiocruz avan\u00e7a com plataforma de vacinas de RNA mensageiro 2025."},{"key":"ref29","series-title":"BRICS joins forces to fight tuberculosis and strengthen vaccine production."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"104739","DOI":"10.1016\/j.respol.2023.104739","article-title":"Vaccine technology transfer in a global health crisis actors, capabilities, and institutions","volume":"52","author":"Fonseca EM","year":"2023","journal-title":"Res Policy"}],"container-title":["Cadernos de Sa\u00fade P\u00fablica"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0102-311X2026000100808&tlng=en","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0102-311X2026000100808&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T10:57:03Z","timestamp":1791802623000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-311X2026000100808&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":30,"alternative-id":["S0102-311X2026000100808"],"URL":"https:\/\/doi.org\/10.1590\/0102-311xen052426","relation":{},"ISSN":["1678-4464","0102-311X"],"issn-type":[{"value":"1678-4464","type":"electronic"},{"value":"0102-311X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e00052426"}}